InvestorsHub Logo
Followers 604
Posts 24107
Boards Moderated 3
Alias Born 12/06/2009

Re: AngryMoose post# 37818

Tuesday, 07/17/2018 7:12:30 PM

Tuesday, July 17, 2018 7:12:30 PM

Post# of 48347
Mr. Moose, Concerning $PPCB and your price target.

I was reading your post and thought I would like to comment for my own thoughts and trading notes.

I wanted to evaluate the risk vs. reward here with $PPCB currently at .033 cents,
and your statements that ".15 is not happening."

I've been watching PPCB for several months, and I think it's possible the bottom may be in here.

I read in their old filings that the Share count was "914,482,130 shares of common stock, $0.001 par value per share, were outstanding as of February 14, 2017."

I read through the old Ihub post and found that at that approximate date of February 2017, the share price was around .011

which would mean the market cap was around $ 9,144,821 (9 million dollars)

Then PPCB did a reverse split to "uplist to a higher exchange"

so all equity was pretty much wiped out, since then the O/S is last known to be 38,324,191 (38 million)

Currently the market cap at yesterdays closing price is $1,226,374 (1.2 million)

lets agree that there was some dilution and lets assume it's now 50 million O/S
that would give a market cap of 1.6 million.

I think 1.6 million market cap is grossly undervaluing a cancer drug.

I believe the PPS could hit a 10 million market cap on news that PPCB has started human clinical trials.

when you look at it from that perspective would you agree? I mean, those notes are for a decent amount of money, but look at the volume coming in here. the notes are being gobbled up it looks like to me.

Chart looks oversold here, a PR about the human clinicals could spark a run from Hell here.. I think .15 cents is not out of the question based on the current situation of this stock.

jmo.